default author photo

Xiangjiao Meng

Shandong Provincial Cancer Hospital

SCHOLARLY PAPERS

2

DOWNLOADS

121

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Efficacy and Safety of IBI351 Monotherapy in KRASG12C-Mutated Metastatic Colorectal Cancer: Results from a Pooled Analysis of Phase I Part of Two Studies

Number of pages: 17 Posted: 15 Oct 2024
Zhejiang University, Sun Yat-sen University (SYSU), Sichuan Cancer Hospital, Fujian Medical University - Department of Medical Oncology, Anhui Provincial Hospital, Hunan Traditional Chinese Medical College, Tangshan People’s Hospital, Government of the People's Republic of China - Department of Oncology, Nanjing Medical University - Department of Oncology, Shandong Provincial Cancer Hospital, Henan University of Science and Technology, China Medical University, Huazhong University of Science and Technology, Tianjin Medical University - Tianjin Cancer Institute, Capital Medical University, Shandong University, Shandong First Medical University, Zhengzhou University, Shandong University, Central South University - Department of Medical Oncology, Anhui Medical University, Huazhong University of Science and Technology - Department of Medical Oncology, Huazhong University of Science and Technology - Hubei Cancer Hospital, Innovent Biologics (Suzhou) Co. Ltd, Innovent Biologics (Suzhou) Co. Ltd, Innovent Biologics (Suzhou) Co. Ltd and Zhejiang University - Department of Colorectal Surgery and Oncology
Downloads 68 (891,180)

Abstract:

Loading...

IBI351, KRASG12C, colorectal cancer, efficacy

2.

Efficacy and Safety of Envafolimab, Suvemcitug and Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer: An Open-Label Phase Ii Clinical Trial

Number of pages: 24 Posted: 10 Jan 2025
Jilin Cancer Hospital - Department of Oncology, Jilin Cancer Hospital, Zhengzhou University - Henan Provincial People's Hospital, Shandong Provincial Cancer Hospital, affiliation not provided to SSRN, The First Affiliated Hospital of Zhengzhou University, affiliation not provided to SSRN, Anhui Medical University, affiliation not provided to SSRN, Anhui Provincial Cancer Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 53 (1,041,696)

Abstract:

Loading...

Non-small cell lung cancer, Suvemcitug, Anti-angiogenesis, Envafolimab, immune checkpoint inhibitor